Search for Clinical Trial Results
Anaplastic Oligoastrocytoma - 21 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas Condition: Brain and Central Nervous System Tumors Date: 2002-04-09 Interventions:
|
Recruiting |
Study Name: A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma Condition:
Date: 2013-12-16 Interventions:
|
Completed |
Study Name: Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial Condition:
Date: 2013-04-29 Interventions: Drug: Temozolomide Temozolomide 200 mg/m2/d in a fasting state for 5 consecutive days (1,000 mg/m2 per 2 |
Recruiting |
Study Name: A Study on β-elemene as Maintain Treatment for Complete Remission Patients of Newly Diagnosed Malignant Gliomas Following Standard Treatment Condition:
Interventions: Drug: β-elemene β-elemene 600mg/d,ivdrip,d1-14,every 28 days for 1 cycle, totally 6 cycles |
Recruiting |
Study Name: A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas Condition:
Interventions: |
Recruiting |
Study Name: Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA Condition:
|
Not yet recruiting |
Study Name: Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas Condition:
|
Withdrawn |
Study Name: Re-irradiation of High Grade Gliomas: a Quality of Life Study Condition:
|
Active, not recruiting |
Study Name: A Study of a Retroviral Replicating Vector Administered to Subjects With Recurrent Malignant Glioma Condition:
|
Active, not recruiting |
Study Name: Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma Condition:
|